Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
20.02
+0.33 (1.68%)
At close: Feb 21, 2025, 4:00 PM
20.30
+0.28 (1.40%)
After-hours: Feb 21, 2025, 5:33 PM EST
KNSA Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for KNSA stock have an average target of 36.6, with a low estimate of 34 and a high estimate of 40. The average target predicts an increase of 82.82% from the current stock price of 20.02.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for KNSA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +99.80% | Nov 5, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +74.83% | Oct 30, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +99.80% | Sep 13, 2024 |
| Wedbush | Wedbush | Buy Maintains $30 → $34 | Buy | Maintains | $30 → $34 | +69.83% | Jul 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $34 | Buy | Initiates | $34 | +69.83% | May 3, 2024 |
Financial Forecast
Revenue This Year
432.68M
from 270.26M
Increased by 60.10%
Revenue Next Year
580.73M
from 432.68M
Increased by 34.22%
EPS This Year
-0.48
from 0.20
EPS Next Year
0.43
from -0.48
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 451.5M | 614.3M | 742.4M | |||
| Avg | 432.7M | 580.7M | 700.6M | |||
| Low | 413.6M | 544.9M | 646.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 67.1% | 42.0% | 27.8% | |||
| Avg | 60.1% | 34.2% | 20.6% | |||
| Low | 53.0% | 25.9% | 11.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.08 | 1.05 | 1.12 | |||
| Avg | -0.48 | 0.43 | 0.84 | |||
| Low | -0.62 | -0.23 | 0.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 159.8% | |||
| Avg | - | - | 93.4% | |||
| Low | - | - | 36.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.